<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac&amp;utm_medium=rss&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac&amp;utm_medium=rss&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Mon, 04 Sep 2023 12:14:45 +0000</lastbuilddate>
<pubDate>Sat, 02 Sep 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Jeanette Erdmann: 1965-2023</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37658790/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 2:ehad563. doi: 10.1093/eurheartj/ehad563. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37658790/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37658790</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad563>10.1093/eurheartj/ehad563</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37658790</guid>
<pubDate>Sat, 02 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Redouane Aherrahrou</dc:creator>
<dc:creator>Marlon Märtens</dc:creator>
<dc:creator>Vera Regitz-Zagrosek</dc:creator>
<dc:creator>Zouhair Aherrahrou</dc:creator>
<dc:date>2023-09-02</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Jeanette Erdmann: 1965-2023</dc:title>
<dc:identifier>pmid:37658790</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad563</dc:identifier>
</item>
<item>
<title>Planting a seed for sustainable hospital menus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37658782/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 2:ehad544. doi: 10.1093/eurheartj/ehad544. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37658782/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37658782</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad544>10.1093/eurheartj/ehad544</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37658782</guid>
<pubDate>Sat, 02 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Jeffrey Zhong</dc:creator>
<dc:creator>Brendan Bourges-Sevenier</dc:creator>
<dc:creator>Paneni Francesco</dc:creator>
<dc:creator>Sanjay Rajagopalan</dc:creator>
<dc:date>2023-09-02</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Planting a seed for sustainable hospital menus</dc:title>
<dc:identifier>pmid:37658782</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad544</dc:identifier>
</item>
<item>
<title>Phage-assisted evolution and protein engineering yield compact, efficient prime editors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37657419/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>Prime editing enables a wide variety of precise genome edits in living cells. Here we use protein evolution and engineering to generate prime editors with reduced size and improved efficiency. Using phage-assisted evolution, we improved editing efficiencies of compact reverse transcriptases by up to 22-fold and generated prime editors that are 516-810 base pairs smaller than the current-generation editor PEmax. We discovered that different reverse transcriptases specialize in different types of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 31;186(18):3983-4002.e26. doi: 10.1016/j.cell.2023.07.039.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Prime editing enables a wide variety of precise genome edits in living cells. Here we use protein evolution and engineering to generate prime editors with reduced size and improved efficiency. Using phage-assisted evolution, we improved editing efficiencies of compact reverse transcriptases by up to 22-fold and generated prime editors that are 516-810 base pairs smaller than the current-generation editor PEmax. We discovered that different reverse transcriptases specialize in different types of edits and used this insight to generate reverse transcriptases that outperform PEmax and PEmaxΔRNaseH, the truncated editor used in dual-AAV delivery systems. Finally, we generated Cas9 domains that improve prime editing. These resulting editors (PE6a-g) enhance therapeutically relevant editing in patient-derived fibroblasts and primary human T-cells. PE6 variants also enable longer insertions to be installed in vivo following dual-AAV delivery, achieving 40% loxP insertion in the cortex of the murine brain, a 24-fold improvement compared to previous state-of-the-art prime editors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37657419/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37657419</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.039>10.1016/j.cell.2023.07.039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37657419</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Jordan L Doman</dc:creator>
<dc:creator>Smriti Pandey</dc:creator>
<dc:creator>Monica E Neugebauer</dc:creator>
<dc:creator>Meirui An</dc:creator>
<dc:creator>Jessie R Davis</dc:creator>
<dc:creator>Peyton B Randolph</dc:creator>
<dc:creator>Amber McElroy</dc:creator>
<dc:creator>Xin D Gao</dc:creator>
<dc:creator>Aditya Raguram</dc:creator>
<dc:creator>Michelle F Richter</dc:creator>
<dc:creator>Kelcee A Everette</dc:creator>
<dc:creator>Samagya Banskota</dc:creator>
<dc:creator>Kathryn Tian</dc:creator>
<dc:creator>Y Allen Tao</dc:creator>
<dc:creator>Jakub Tolar</dc:creator>
<dc:creator>Mark J Osborn</dc:creator>
<dc:creator>David R Liu</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Phage-assisted evolution and protein engineering yield compact, efficient prime editors</dc:title>
<dc:identifier>pmid:37657419</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.039</dc:identifier>
</item>
<item>
<title>Biomarkers of aging for the identification and evaluation of longevity interventions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37657418/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>With the rapid expansion of aging biology research, the identification and evaluation of longevity interventions in humans have become key goals of this field. Biomarkers of aging are critically important tools in achieving these objectives over realistic time frames. However, the current lack of standards and consensus on the properties of a reliable aging biomarker hinders their further development and validation for clinical applications. Here, we advance a framework for the terminology and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 31;186(18):3758-3775. doi: 10.1016/j.cell.2023.08.003.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">With the rapid expansion of aging biology research, the identification and evaluation of longevity interventions in humans have become key goals of this field. Biomarkers of aging are critically important tools in achieving these objectives over realistic time frames. However, the current lack of standards and consensus on the properties of a reliable aging biomarker hinders their further development and validation for clinical applications. Here, we advance a framework for the terminology and characterization of biomarkers of aging, including classification and potential clinical use cases. We discuss validation steps and highlight ongoing challenges as potential areas in need of future research. This framework sets the stage for the development of valid biomarkers of aging and their ultimate utilization in clinical trials and practice.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37657418/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37657418</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.003>10.1016/j.cell.2023.08.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37657418</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Mahdi Moqri</dc:creator>
<dc:creator>Chiara Herzog</dc:creator>
<dc:creator>Jesse R Poganik</dc:creator>
<dc:creator>Biomarkers of Aging Consortium</dc:creator>
<dc:creator>Jamie Justice</dc:creator>
<dc:creator>Daniel W Belsky</dc:creator>
<dc:creator>Albert Higgins-Chen</dc:creator>
<dc:creator>Alexey Moskalev</dc:creator>
<dc:creator>Georg Fuellen</dc:creator>
<dc:creator>Alan A Cohen</dc:creator>
<dc:creator>Ivan Bautmans</dc:creator>
<dc:creator>Martin Widschwendter</dc:creator>
<dc:creator>Jingzhong Ding</dc:creator>
<dc:creator>Alexander Fleming</dc:creator>
<dc:creator>Joan Mannick</dc:creator>
<dc:creator>Jing-Dong Jackie Han</dc:creator>
<dc:creator>Alex Zhavoronkov</dc:creator>
<dc:creator>Nir Barzilai</dc:creator>
<dc:creator>Matt Kaeberlein</dc:creator>
<dc:creator>Steven Cummings</dc:creator>
<dc:creator>Brian K Kennedy</dc:creator>
<dc:creator>Luigi Ferrucci</dc:creator>
<dc:creator>Steve Horvath</dc:creator>
<dc:creator>Eric Verdin</dc:creator>
<dc:creator>Andrea B Maier</dc:creator>
<dc:creator>Michael P Snyder</dc:creator>
<dc:creator>Vittorio Sebastiano</dc:creator>
<dc:creator>Vadim N Gladyshev</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Biomarkers of aging for the identification and evaluation of longevity interventions</dc:title>
<dc:identifier>pmid:37657418</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.003</dc:identifier>
</item>
<item>
<title>Seven days in the life cycle of Homo sapiens</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37657417/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>The second week of embryonic development is a critical phase of the human life cycle and one that has been largely inaccessible to scientific investigation. Recent studies of human embryo models built from stem cells promise to yield dramatic insights into the key events of cell specification and morphogenesis that occur during this brief window of embryogenesis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 31;186(18):3755-3757. doi: 10.1016/j.cell.2023.08.007.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The second week of embryonic development is a critical phase of the human life cycle and one that has been largely inaccessible to scientific investigation. Recent studies of human embryo models built from stem cells promise to yield dramatic insights into the key events of cell specification and morphogenesis that occur during this brief window of embryogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37657417/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37657417</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.007>10.1016/j.cell.2023.08.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37657417</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Martin F Pera</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Seven days in the life cycle of Homo sapiens</dc:title>
<dc:identifier>pmid:37657417</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.007</dc:identifier>
</item>
<item>
<title>Haunting innate immune memories of COVID-19</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37657416/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>In addition to acute hyperinflammatory responses, SARS-CoV-2 infections can have long-term effects on our immune system leading to, for example, post-acute sequelae of COVID-19 (PASC). In this issue of Cell, Cheong et al. show that severe infections via IL-6 induce persistent epigenetic signatures in hemopoietic stem cells and their myeloid progenitors associated with increased inflammatory potential.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 31;186(18):3753-3755. doi: 10.1016/j.cell.2023.07.033.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In addition to acute hyperinflammatory responses, SARS-CoV-2 infections can have long-term effects on our immune system leading to, for example, post-acute sequelae of COVID-19 (PASC). In this issue of Cell, Cheong et al. show that severe infections via IL-6 induce persistent epigenetic signatures in hemopoietic stem cells and their myeloid progenitors associated with increased inflammatory potential.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37657416/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37657416</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.033>10.1016/j.cell.2023.07.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37657416</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Birgit Sawitzki</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Haunting innate immune memories of COVID-19</dc:title>
<dc:identifier>pmid:37657416</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.033</dc:identifier>
</item>
<item>
<title>Bridge-building between communities: Imagining the future of biomedical autism research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37657415/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>A paradigm shift in research culture is required to ease perceived tensions between autistic people and the biomedical research community. As a group of autistic and non-autistic scientists and stakeholders, we contend that through participatory research, we can reject a deficit-based conceptualization of autism while building a shared vision for a neurodiversity-affirmative biomedical research paradigm.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 31;186(18):3747-3752. doi: 10.1016/j.cell.2023.08.004.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A paradigm shift in research culture is required to ease perceived tensions between autistic people and the biomedical research community. As a group of autistic and non-autistic scientists and stakeholders, we contend that through participatory research, we can reject a deficit-based conceptualization of autism while building a shared vision for a neurodiversity-affirmative biomedical research paradigm.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37657415/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37657415</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.004>10.1016/j.cell.2023.08.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37657415</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Síofra Heraty</dc:creator>
<dc:creator>Alexandra Lautarescu</dc:creator>
<dc:creator>David Belton</dc:creator>
<dc:creator>Alison Boyle</dc:creator>
<dc:creator>Pietro Cirrincione</dc:creator>
<dc:creator>Mary Doherty</dc:creator>
<dc:creator>Sarah Douglas</dc:creator>
<dc:creator>Jan Roderik Derk Plas</dc:creator>
<dc:creator>Katrien Van Den Bosch</dc:creator>
<dc:creator>Pierre Violland</dc:creator>
<dc:creator>Jerneja Tercon</dc:creator>
<dc:creator>Amber Ruigrok</dc:creator>
<dc:creator>Declan G M Murphy</dc:creator>
<dc:creator>Thomas Bourgeron</dc:creator>
<dc:creator>Christopher Chatham</dc:creator>
<dc:creator>Eva Loth</dc:creator>
<dc:creator>Bethany Oakley</dc:creator>
<dc:creator>Grainne M McAlonan</dc:creator>
<dc:creator>Tony Charman</dc:creator>
<dc:creator>Nicolaas Puts</dc:creator>
<dc:creator>Louise Gallagher</dc:creator>
<dc:creator>Emily J H Jones</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Bridge-building between communities: Imagining the future of biomedical autism research</dc:title>
<dc:identifier>pmid:37657415</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.004</dc:identifier>
</item>
<item>
<title>Donald Brown (1931-2023)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37657414/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 31;186(18):3745-3746. doi: 10.1016/j.cell.2023.07.032.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37657414/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37657414</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.032>10.1016/j.cell.2023.07.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37657414</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Douglas Koshland</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Donald Brown (1931-2023)</dc:title>
<dc:identifier>pmid:37657414</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.032</dc:identifier>
</item>
<item>
<title>Erratum to: Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37656892/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 1:ehad439. doi: 10.1093/eurheartj/ehad439. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37656892/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37656892</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad439>10.1093/eurheartj/ehad439</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37656892</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:date>2023-09-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Erratum to: Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy</dc:title>
<dc:identifier>pmid:37656892</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad439</dc:identifier>
</item>
<item>
<title>Reducing the risks of nuclear war: the role of health professionals†</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37655648/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 1:ehad542. doi: 10.1093/eurheartj/ehad542. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37655648/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37655648</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad542>10.1093/eurheartj/ehad542</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37655648</guid>
<pubDate>Fri, 01 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Kamran Abbasi</dc:creator>
<dc:creator>Parveen Ali</dc:creator>
<dc:creator>Virginia Barbour</dc:creator>
<dc:creator>Kirsten Bibbins-Domingo</dc:creator>
<dc:creator>Marcel G M Olde Rikkert</dc:creator>
<dc:creator>Peng Gong</dc:creator>
<dc:creator>Andy Haines</dc:creator>
<dc:creator>Ira Helfand</dc:creator>
<dc:creator>Richard Horton</dc:creator>
<dc:creator>Bob Mash</dc:creator>
<dc:creator>Arun Mitra</dc:creator>
<dc:creator>Carlos Monteiro</dc:creator>
<dc:creator>Elena N Naumova</dc:creator>
<dc:creator>Eric J Rubin</dc:creator>
<dc:creator>Tilman Ruff</dc:creator>
<dc:creator>Peush Sahni</dc:creator>
<dc:creator>James Tumwine</dc:creator>
<dc:creator>Paul Yonga</dc:creator>
<dc:creator>Chris Zielinski</dc:creator>
<dc:date>2023-09-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Reducing the risks of nuclear war: the role of health professionals†</dc:title>
<dc:identifier>pmid:37655648</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad542</dc:identifier>
</item>
<item>
<title>TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37652892/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 1;44(33):3105-3109. doi: 10.1093/eurheartj/ehad533.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37652892/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37652892</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad533>10.1093/eurheartj/ehad533</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37652892</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?</dc:title>
<dc:identifier>pmid:37652892</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad533</dc:identifier>
</item>
<item>
<title>Structural basis for ion selectivity in potassium-selective channelrhodopsins</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37652010/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>KCR channelrhodopsins (K^(+)-selective light-gated ion channels) have received attention as potential inhibitory optogenetic tools but more broadly pose a fundamental mystery regarding how their K^(+) selectivity is achieved. Here, we present 2.5-2.7 Å cryo-electron microscopy structures of HcKCR1 and HcKCR2 and of a structure-guided mutant with enhanced K^(+) selectivity. Structural, electrophysiological, computational, spectroscopic, and biochemical analyses reveal a distinctive mechanism for...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 30:S0092-8674(23)00863-2. doi: 10.1016/j.cell.2023.08.009. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">KCR channelrhodopsins (K<sup>+</sup>-selective light-gated ion channels) have received attention as potential inhibitory optogenetic tools but more broadly pose a fundamental mystery regarding how their K<sup>+</sup> selectivity is achieved. Here, we present 2.5-2.7 Å cryo-electron microscopy structures of HcKCR1 and HcKCR2 and of a structure-guided mutant with enhanced K<sup>+</sup> selectivity. Structural, electrophysiological, computational, spectroscopic, and biochemical analyses reveal a distinctive mechanism for K<sup>+</sup> selectivity; rather than forming the symmetrical filter of canonical K<sup>+</sup> channels achieving both selectivity and dehydration, instead, three extracellular-vestibule residues within each monomer form a flexible asymmetric selectivity gate, while a distinct dehydration pathway extends intracellularly. Structural comparisons reveal a retinal-binding pocket that induces retinal rotation (accounting for HcKCR1/HcKCR2 spectral differences), and design of corresponding KCR variants with increased K<sup>+</sup> selectivity (KALI-1/KALI-2) provides key advantages for optogenetic inhibition in vitro and in vivo. Thus, discovery of a mechanism for ion-channel K<sup>+</sup> selectivity also provides a framework for next-generation optogenetics.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37652010/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37652010</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.009>10.1016/j.cell.2023.08.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37652010</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Seiya Tajima</dc:creator>
<dc:creator>Yoon Seok Kim</dc:creator>
<dc:creator>Masahiro Fukuda</dc:creator>
<dc:creator>YoungJu Jo</dc:creator>
<dc:creator>Peter Y Wang</dc:creator>
<dc:creator>Joseph M Paggi</dc:creator>
<dc:creator>Masatoshi Inoue</dc:creator>
<dc:creator>Eamon F X Byrne</dc:creator>
<dc:creator>Koichiro E Kishi</dc:creator>
<dc:creator>Seiwa Nakamura</dc:creator>
<dc:creator>Charu Ramakrishnan</dc:creator>
<dc:creator>Shunki Takaramoto</dc:creator>
<dc:creator>Takashi Nagata</dc:creator>
<dc:creator>Masae Konno</dc:creator>
<dc:creator>Masahiro Sugiura</dc:creator>
<dc:creator>Kota Katayama</dc:creator>
<dc:creator>Toshiki E Matsui</dc:creator>
<dc:creator>Keitaro Yamashita</dc:creator>
<dc:creator>Suhyang Kim</dc:creator>
<dc:creator>Hisako Ikeda</dc:creator>
<dc:creator>Jaeah Kim</dc:creator>
<dc:creator>Hideki Kandori</dc:creator>
<dc:creator>Ron O Dror</dc:creator>
<dc:creator>Keiichi Inoue</dc:creator>
<dc:creator>Karl Deisseroth</dc:creator>
<dc:creator>Hideaki E Kato</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Structural basis for ion selectivity in potassium-selective channelrhodopsins</dc:title>
<dc:identifier>pmid:37652010</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.009</dc:identifier>
</item>
<item>
<title>Will Induction of Transient Myocyte Proliferation Be a Regenerative Therapy?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37651544/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Sep;133(6):505-507. doi: 10.1161/CIRCRESAHA.123.323399. Epub 2023 Aug 31.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37651544/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37651544</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323399>10.1161/CIRCRESAHA.123.323399</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37651544</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Steven R Houser</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Will Induction of Transient Myocyte Proliferation Be a Regenerative Therapy?</dc:title>
<dc:identifier>pmid:37651544</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323399</dc:identifier>
</item>
<item>
<title>Integrated Pathogenesis of Vascular and Cardiac Valve Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37651543/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Sep;133(6):481-483. doi: 10.1161/CIRCRESAHA.123.323451. Epub 2023 Aug 31.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37651543/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37651543</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323451>10.1161/CIRCRESAHA.123.323451</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37651543</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Timothy J Cashman</dc:creator>
<dc:creator>Timothy P Fitzgibbons</dc:creator>
<dc:creator>Chinmay M Trivedi</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Integrated Pathogenesis of Vascular and Cardiac Valve Disease</dc:title>
<dc:identifier>pmid:37651543</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323451</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37651541/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Sep;133(6):448-449. doi: 10.1161/RES.0000000000000631. Epub 2023 Aug 31.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37651541/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37651541</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000631>10.1161/RES.0000000000000631</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37651541</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-31</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37651541</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000631</dc:identifier>
</item>
<item>
<title>Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37650505/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 31:ehad518. doi: 10.1093/eurheartj/ehad518. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37650505/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37650505</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad518>10.1093/eurheartj/ehad518</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37650505</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Adaya Weissler-Snir</dc:creator>
<dc:creator>Harry Rakowski</dc:creator>
<dc:creator>Markus Meyer</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?</dc:title>
<dc:identifier>pmid:37650505</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad518</dc:identifier>
</item>
<item>
<title>Optimal Measurement of Coronary Flow and Microvascular Function in Animals and Humans</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37650288/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 31. doi: 10.1161/CIRCRESAHA.123.323341. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37650288/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37650288</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323341>10.1161/CIRCRESAHA.123.323341</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37650288</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Lennert Minten</dc:creator>
<dc:creator>Michiel Algoet</dc:creator>
<dc:creator>Johan Bennett</dc:creator>
<dc:creator>Wouter Oosterlinck</dc:creator>
<dc:creator>Bart Meuris</dc:creator>
<dc:creator>Tom Langenaeken</dc:creator>
<dc:creator>Stephanie Bézy</dc:creator>
<dc:creator>Laurine Wouters</dc:creator>
<dc:creator>Jürgen Duchenne</dc:creator>
<dc:creator>Alexis Puvrez</dc:creator>
<dc:creator>Senne de Groote</dc:creator>
<dc:creator>Pierluigi Lesizza</dc:creator>
<dc:creator>Pascal Frederiks</dc:creator>
<dc:creator>Laurens de Vos</dc:creator>
<dc:creator>Tom Adriaenssens</dc:creator>
<dc:creator>Peter Sinnaeve</dc:creator>
<dc:creator>Walter Desmet</dc:creator>
<dc:creator>Keir McCutcheon</dc:creator>
<dc:creator>Christophe Dubois</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Optimal Measurement of Coronary Flow and Microvascular Function in Animals and Humans</dc:title>
<dc:identifier>pmid:37650288</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323341</dc:identifier>
</item>
<item>
<title>Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37650264/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: A real-time, targeted, and tailored EHR-based alert system for AHF did not lead to a higher number of overall GDMT prescriptions at discharge. Further refinement and improvement of such alerts and changes to clinician incentives are needed to overcome barriers to the implementation of GDMT during hospitalizations for AHF. GDMT remains suboptimal in this setting, with only one in nine patients being discharged on a comprehensive evidence-based regimen for heart failure.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 31:ehad512. doi: 10.1093/eurheartj/ehad512. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Patients hospitalized for acute heart failure (AHF) continue to be discharged on an inadequate number of guideline-directed medical therapies (GDMT) despite evidence that inpatient initiation is beneficial. This study aimed to examine whether a tailored electronic health record (EHR) alert increased rates of GDMT prescription at discharge in eligible patients hospitalized for AHF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Pragmatic trial of messaging to providers about treatment of acute heart failure (PROMPT-AHF) was a pragmatic, multicenter, EHR-based, and randomized clinical trial. Patients were automatically enrolled 48 h after admission if they met pre-specified criteria for an AHF hospitalization. Providers of patients in the intervention arm received an alert during order entry with relevant patient characteristics along with individualized GDMT recommendations with links to an order set. The primary outcome was an increase in the number of GDMT prescriptions at discharge.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Thousand and twelve patients were enrolled between May 2021 and November 2022. The median age was 74 years; 26% were female, and 24% were Black. At the time of the alert, 85% of patients were on β-blockers, 55% on angiotensin-converting enzyme inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, 20% on mineralocorticoid receptor antagonist (MRA) and 17% on sodium-glucose cotransporter 2 inhibitor. The primary outcome occurred in 34% of both the alert and no alert groups [adjusted risk ratio (RR): 0.95 (0.81, 1.12), P = .99]. Patients randomized to the alert arm were more likely to have an increase in MRA [adjusted RR: 1.54 (1.10, 2.16), P = .01]. At the time of discharge, 11.2% of patients were on all four pillars of GDMT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: A real-time, targeted, and tailored EHR-based alert system for AHF did not lead to a higher number of overall GDMT prescriptions at discharge. Further refinement and improvement of such alerts and changes to clinician incentives are needed to overcome barriers to the implementation of GDMT during hospitalizations for AHF. GDMT remains suboptimal in this setting, with only one in nine patients being discharged on a comprehensive evidence-based regimen for heart failure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37650264/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37650264</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad512>10.1093/eurheartj/ehad512</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37650264</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Lama Ghazi</dc:creator>
<dc:creator>Yu Yamamoto</dc:creator>
<dc:creator>Michael Fuery</dc:creator>
<dc:creator>Kyle O'Connor</dc:creator>
<dc:creator>Sounok Sen</dc:creator>
<dc:creator>Marc Samsky</dc:creator>
<dc:creator>Ralph J Riello</dc:creator>
<dc:creator>Ravi Dhar</dc:creator>
<dc:creator>Joanna Huang</dc:creator>
<dc:creator>Temitope Olufade</dc:creator>
<dc:creator>James McDermott</dc:creator>
<dc:creator>Silvio E Inzucchi</dc:creator>
<dc:creator>Eric J Velazquez</dc:creator>
<dc:creator>Francis Perry Wilson</dc:creator>
<dc:creator>Nihar R Desai</dc:creator>
<dc:creator>Tariq Ahmad</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial</dc:title>
<dc:identifier>pmid:37650264</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad512</dc:identifier>
</item>
<item>
<title>Intranasal 'spray-in-the-pocket' treatment for conversion of supraventricular tachycardia: safe, effective but not definite</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37650261/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 31:ehad502. doi: 10.1093/eurheartj/ehad502. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37650261/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37650261</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad502>10.1093/eurheartj/ehad502</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37650261</guid>
<pubDate>Thu, 31 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Maria Lucia Narducci</dc:creator>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:date>2023-08-31</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Intranasal 'spray-in-the-pocket' treatment for conversion of supraventricular tachycardia: safe, effective but not definite</dc:title>
<dc:identifier>pmid:37650261</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad502</dc:identifier>
</item>
<item>
<title>Reply: Nonculprit Lesion Location and Outcomes From the CULPRIT-SHOCK Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37648361/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Sep 5;82(10):e87-e88. doi: 10.1016/j.jacc.2023.06.028.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37648361/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37648361</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.06.028>10.1016/j.jacc.2023.06.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37648361</guid>
<pubDate>Wed, 30 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Uwe Zeymer</dc:creator>
<dc:creator>Taoufik Ouarrak</dc:creator>
<dc:creator>Steffen Desch</dc:creator>
<dc:creator>Holger Thiele</dc:creator>
<dc:date>2023-08-30</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Nonculprit Lesion Location and Outcomes From the CULPRIT-SHOCK Trial</dc:title>
<dc:identifier>pmid:37648361</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.06.028</dc:identifier>
</item>
<item>
<title>Nonculprit Lesion Location and Outcomes From the CULPRIT-SHOCK Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37648360/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230904081444&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Sep 5;82(10):e85. doi: 10.1016/j.jacc.2023.04.062.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37648360/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230904081444&v=2.17.9.post6+86293ac">37648360</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.04.062>10.1016/j.jacc.2023.04.062</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37648360</guid>
<pubDate>Wed, 30 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Ahmed Elkaryoni</dc:creator>
<dc:creator>Gregg W Stone</dc:creator>
<dc:date>2023-08-30</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Nonculprit Lesion Location and Outcomes From the CULPRIT-SHOCK Trial</dc:title>
<dc:identifier>pmid:37648360</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.04.062</dc:identifier>
</item>





























</channel>
</rss>